Your browser doesn't support javascript.
loading
Patient Blood Type Is Associated With Response to Immune Checkpoint Blockade in Metastatic Cancer.
Chen, Ruifeng; Hakimi, Kasim; Zhang, Xinlian; Messer, Karen; Patel, Sandip Pravin.
  • Chen R; Herbert Wertheim School of Public Health and Human Longevity Science, University of California San Diego, La Jolla, CA, USA.
  • Hakimi K; University of California San Diego, Moores Cancer Center, La Jolla, CA, USA.
  • Zhang X; Division of Hematology & Medical Oncology, Department of Medicine, University of California San Diego, La Jolla, CA, USA.
  • Messer K; Herbert Wertheim School of Public Health and Human Longevity Science, University of California San Diego, La Jolla, CA, USA.
  • Patel SP; University of California San Diego, Moores Cancer Center, La Jolla, CA, USA.
Oncologist ; 27(9): e739-e747, 2022 09 02.
Article en En | MEDLINE | ID: mdl-35816018
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Primarias Secundarias / Neoplasias Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Primarias Secundarias / Neoplasias Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article